4SC to Present at Two Upcoming Investor Conferences

News Apr 17, 2012

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will be presenting at two investor conferences this week.

Dr Ulrich Dauer, Chief Executive Officer of 4SC AG, will give a company presentation at the Future Leaders in the Biotech Industry conference, which will be held on 20 April 2012 in New York City, USA.

The presentation of 4SC will begin at 9.00am (ET).

Enno Spillner, Chief Financial Officer of 4SC AG, will give a company presentation at the 3rd FCF Family-to-Family Day, an investor conference exclusively for family offices and HNIs (High Net Worth Individuals) on 19 April 2012 in Munich.

The presentation of 4SC will begin at 3.15pm (CET).

Scientists Develop New Drug Treatment for TB

News

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. The team hope the compound –developed after 10 years of painstaking research will be trialed on humans within three to four years.

Novel Drug Designed for Pancreatic Cancer

News

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

A New Generation of Pain Meds

News

Researchers have developed a new generation of pain medications. The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation.

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free